Finanzas de Aeon Biopharma Inc (AEON)

$0.277

-0.018 (-6.52%)Al cierre

Comparativa sectorial de AEON

In the context of the broader market, AEON competes directly with industry leaders such as HIND and NRSN. With a market capitalization of $15.67M, it holds a significant position in the sector. When comparing efficiency, AEON's gross margin of N/A stands against HIND's 33.57% and NRSN's N/A. Such benchmarking helps identify whether Aeon Biopharma Inc is trading at a premium or discount relative to its financial performance.

Desempeño financiero de Aeon Biopharma Inc

Aeon Biopharma has shown a volatile financial performance with significant net losses, including -11,793,000 USD in Q1 2026 and a forward P/E of 1.1577, indicating potential for future earnings growth if the company can stabilize.

Financials

FY2026Q2

YoY:

+37.18%

-5.93M

Operating Profit

FY2026Q2

YoY:

-82.61%

-1.16M

Net Income after Tax

FY2026Q2

YoY:

-96.67%

-0.02

EPS - Diluted

FY2026Q1

YoY:

-66.69%

-2.64M

Free Cash Flow

FY2026Q2

YoY:

+37.18%

-5.93M

Operating Profit

FY2026Q2

YoY:

-82.61%

-1.16M

Net Income after Tax

FY2026Q2

YoY:

-96.67%

-0.02

EPS - Diluted

FY2026Q1

YoY:

-66.69%

-2.64M

Free Cash Flow

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.